Valuing health outcomes for health technology assessment
A UK-China Health and Economy Partnership Workshop
17-18 November 2020
UK-CHEP short summary
The UK-China Health and Economy Partnership is a novel knowledge transfer partnership that will promote long-term collaboration between Bournemouth University, University of York, University of Sheffield and University of Leeds in the UK and Fudan University, Shandong University and Zhejiang University in China.
The partnership aims to create long-term, sustainable collaboration in health economics, which will give UK and Chinese academics the means to work together on world-class educational and research outcomes that would otherwise not be possible working in isolation.
This partnership was originally launched in Jinan, Shandong province in November 2017 by Bournemouth University. GlaxoSmithKline and the British Council have extended the partnership for a further two years, from January 2019.
Three workshops have been arranged as part of UK-CHEP in 2020 and 2021. This workshop by Shandong University and the University of Sheffield is the first. The second has been developed by Leeds and-Zhejiang universities; details are available here. The third has been developed by York and-Fudan universities; details are available here.
- Workshop summary
-
The workshop will explore how health outcomes can be measured and valued for use in health technology assessment. This topic is an area of expertise for both Sheffield and Shandong Universities. Presentations will be given by world leading experts in health valuation methodologies and the sessions will be chaired by Partnership Leads, Professors Sun Qiang (Shandong University) and Simon Dixon (University of Sheffield).
The presenters are:
- Professor Simon Dixon, University of Sheffield
- Professor John Brazier, Dean of the School of Health and Related Research, University of Sheffield
- Dr Praveen Thokala, University of Sheffield
- Professor Shunping Li, Shandong University
- Dr Zhuxin Mao, Shandong University
- Dr Xiaoning He, Tianjin University and Visiting Fellow at University of Sheffield
- Professor Sun Qiang, Shandong University
The workshop will take place on 17th-18th November 2020. The workshop will take place in person at Shandong University and online throughout China and the UK. Attendance is by invitation only, but all materials will be available online.
- Speaker biographies
-
Professor Simon Dixon
Simon leads the Sheffield component of UK-CHEP. He is an expert in economic evaluation and health technology assessment methods. He spent 10 years on a NICE Technology Assessment panel applying these methods to real world decision making. He leads modules on ScHARR’s Masters in Public Health (MPH) and MSc International Health Technology Assessment and Reimbursement.
Professor John Brazier
John is one of the world’s leading researchers in the field of preference-based measures. He developed the SF-6D over 20 years ago and has led the development of new methods and measures since that time. He is currently leading work on a new measure commissioned by the UK Department of Health and is collaborating with Chinese researchers to examine its validity in China.
Dr Praveen Thokala
Praveen is an expert in decision analytic modelling and multi-criteria decision analyses (MCDA). Praveen has undertaken modelling on numerous projects for NICE, ICER and the National Institute for Health Research. He was Chairman of the ISPOR MCDA Emerging Good Practices Task Force which produced good practice guidelines that are used throughout the world.
Professor Sun Qiang
Qiang Sun leads the Shandong component of UK-CHEP. He serves as the chief expert of the key new think tank (health management and policy research) in Shandong Province and the deputy chairman of the Public Health Economics Branch of the Chinese Health Economics. He is an expert in health economy and health policy. Over the past two decades, he has been committed to promoting the rational use of antibiotics, conducting health economic evaluation, and accelerating the reform of medical insurance payment methods. His series of research results provide a strong basis for the formulation of national health policy.
Professor Shunping Li
Shunping Li is the director of Center for Health Preference, Shandong University, deputy director of the Key Laboratory of Health Economics and Policy Research of National Health Commission. His main research interests include: [1] the design and analysis of discrete choice experiment for the quantification of stakeholder preferences for health and health care; [2] the measurement and valuation of health outcomes; [3] to assess the cost effectiveness of health related interventions and to contribute to the design and analysis of clinical trials.
Dr Zhuxin Mao
Mao Zhuxin graduated with the Master’s degree with distinction in business and economics from University College London in 2016 and just obtained her PhD degree in health economics from Academic Unit of Health Economics, University of Leeds, 2020. Her PhD research was about exploring cultural differences in defining and measuring health between China and the West. Her key research areas include health-related quality of life & patient reported outcomes, health status measurement & evaluation and patient preference. Upon graduation, Zhuxin will continue to conduct health economics and outcome research in China and internationally.
Dr Xiaoning He
Xiaoning He is an assistant Prof. in School of Pharmaceutical Science and Technology, Tianjin University, major in pharmacoeconomics. She visited Sheffield University from Sep 2019 and Mar 2020 as a visiting scholar. Her main research areas are real-world data analyses, pharmacoeconomic evaluations, and health utility measurement. She also worked as group members of China Pharmacoeconomic Guideline 2020, and several other Chinese textbooks of pharmacoeconomics in China.
Professor Darrin Baines
Professor Darrin Baines is a health economist who specialises in health policy and the evaluation of health systems. He has published widely in international journal and is currently the coordinating lead of the UK-China Health and Economy Partnership. Professor Baines is also the academic lead of a British Council funded Newton project currently transferring health economics expertise to pharmacists in Egypt. His website is: darrinbaines.net
- Workshop timetable
-
Day 1 Morning: Register
Day 1 Afternoon: Measuring and Valuing Outcomes for Health Technology Assessment (Part 1)
China time
UK time
Title
Presenter
15:30
07:30
Welcome
Professor Sun Qiang, Shandong University
15:35
07:35
Introduction from the British Council about the UK-China program
Professor Darrin Baines, University of Bournemouth
15:45
07:45
Key issues when measuring and valuing health: a European and North American perspective
Professor Simon Dixon, University of Sheffield
16:15
08:15
The development, use and future of the SF-6D
Professor John Brazier, University of Sheffield
16:45
08:45
Coffee break
17:00
09:00
Discussion
Lead by Sun Qiang and Simon Dixon
17:45
09:45
Summary
Professor Simon Dixon, University of Sheffield
18:00
10:00
Homework: What are the key issues when measuring and valuing health in China?"
Professor Li Shunping
Day 2: Measuring and Valuing Outcomes for Health Technology Assessment (Part 2)
China time
UK time
Title
Presenter
09:00
01:00
Feedback to the lecture and the homework
Professor Sun Qiang, Shandong University
10:00
02:00
Introduction and comparison of MAU instruments
Professor Shunping Li, Shandong University
10:30
02:30
Break
10:45
02:45
Similarities and Differences in HRQOL concepts between China and the West
Dr Zhuxin Mao, Shandong University
11:15
02:15
Meauring and valuing health for HTA in children
Professor Simon Dixon, University of Sheffield
11:45
03:45
Discussion and Summary
12:00
04:00
Lunch and break
15:30
07:30
Welcome
Professor Sun Qiang, Shandong University
15:35
07:35
E-QALY project
Professor John Brazier, University of Sheffield
16:00
08:00
E-QALY in China
Dr Xiaoning He,
Tianjin University
16:30
08:30
Discussion
17:15
09:15
Break
17:30
09:30
Diagnostic modelling for suspected acute coronary syndrome
Dr Praveen Thokala, Univesity of Sheffield
18:00
10:00
Discussion
18:15
11:15
Summary
Professor Simon Dixon, University of Sheffield
Professor Sun Qiang, Shandong University
- Workshop resources
-
Presentations:
Key issues when measuring and valuing health: a European and North American perspective (Simon Dixon)Development, use and future of the SF-6D preference-based measure of health (John Brazier)Similarities and Differences in Measuring Health between China and the West (Zhuxin Mao)Introduction and comparison of MAU instruments (Shunping Li)Measuring and valuing health in children for HTA (Simon Dixon)Developing a broader QALY instrument to capture health and wellbeing: the 'Extending the QALY' project (John Brazier)Cost-effectiveness of diagnostic strategies for suspected acute coronary syndrome (Praveen Thokala)
- Introductory Videos
-
The following videos have been produced by the University of Sheffield for it’s Massive Open Online Courses (MOOCs) and provide an excellent introduction to many of the topics covered by the workshop:
Using QALY information in decision making
The challenge of creating a generic measure of HRQOL
Who should value child outcomes?
Valuing Health States in Practice
- Press release
- Workshop report
- Further resources
-
Important resources for anyone wanting to know more about valuing health outcomes for health technology assessment are listed below.
Face-to-face courses that include this topic:
- MSc/PG Diploma/PG Certificate Health Economics and Decision Modelling, University of Sheffield
- MSc Social Medicine and Health Care Management
Online courses that include this topic
- MSc/PG Diploma/PG Certificate International Health Technology Assessment, University of Sheffield
- Utility and Patient-Reported Outcomes Data in HTA, University of Sheffield
Massive open online courses (MOOCs)
- Valuing Health: quality adjusted life years and patient reported outcome measures explores how and why choices about drugs and treatments have been made
- Health Technology Assessment: choosing which treatments get funded looks at how the effectiveness and cost of new drugs or treatments are assessed before they can be adopted
Books